HERON THERAPEUTICS earnings per share and revenue

AXD2 earnings per share for the last quarter are 0.02 CHF whereas the estimation was -0.03 CHF which accounts for 165.47% surprise. Company revenue for the same period amounts to 37.04 M CHF despite the estimated figure of 33.87 M CHF. Estimated earnings per share for the next quarter are -0.01 CHF, and revenue is expected to reach 33.15 M CHF. Also watch annual changes over time to get a bigger picture of AXD2 earnings per share and revenue dynamics.